Apelin is a novel islet peptide

Regulatory Peptides

Volumn 162, Issue 1-3, 2010, Pages 44-51

  Ringström, Camilla ^a   Nitert, Marloes Dekker ^b   Bennet, Hedvig ^b   Fex, Malin ^b   Valet, Philippe ^c   Rehfeld, Jens F ^d   Friis Hansen, Lennart ^d   Wierup, Nils ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY DIABETES CENTRE   (Sweden)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Apelin; APJ receptor; Immunocytochemistry; Insulin secretion; Islets; Type 2 diabetes

Indexed keywords

APELIN; APELIN 36; APELIN RECEPTOR; GLUCOCORTICOID; GLUCOSE; INSULIN; NEUROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FETUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN RELEASE; INSULINOMA; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SWINE;

ANIMALS; CARRIER PROTEINS; CELL LINE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; MICE; POLYMERASE CHAIN REACTION; RATS;

ANIMALIA; FELIDAE; MURINAE; MUS; RATTUS; SUS;

EID: 77952669438     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.03.005     Document Type: Article

References (44)

1. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M.X., Kawamata Y., Fukusumi S., Hinuma S., Kitada C., Kurokawa T., Onda H., Fujino M. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998, 251:471-476.
2. O'Dowd B.F., Heiber M., Chan A., Heng H.H., Tsui L.C., Kennedy J.L., Shi X., Petronis A., George S.R., Nguyen T. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993, 136:355-360.
3. Hosoya M., Kawamata Y., Fukusumi S., Fujii R., Habata Y., Hinuma S., Kitada C., Honda S., Kurokawa T., Onda H., Nishimura O., Fujino M. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 2000, 275:21061-21067.
4. Kawamata Y., Habata Y., Fukusumi S., Hosoya M., Fujii R., Hinuma S., Nishizawa N., Kitada C., Onda H., Nishimura O., Fujino M. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 2001, 1538:162-171.
5. Ladeiras-Lopes R., Ferreira-Martins J., Leite-Moreira A.F. The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications. Arq Bras Cardiol 2008, 90:343-349.
6. Edinger A.L., Hoffman T.L., Sharron M., Lee B., Yi Y., Choe W., Kolson D.L., Mitrovic B., Zhou Y., Faulds D., Collman R.G., Hesselgesser J., Horuk R., Doms R.W. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus. J Virol 1998, 72:7934-7940.
7. Reaux A., De Mota N., Skultetyova I., Lenkei Z., El Messari S., Gallatz K., Corvol P., Palkovits M., Llorens-Cortes C. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 2001, 77:1085-1096.
8. Medhurst A.D., Jennings C.A., Robbins M.J., Davis R.P., Ellis C., Winborn K.Y., Lawrie K.W., Hervieu G., Riley G., Bolaky J.E., Herrity N.C., Murdock P., Darker J.G. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 2003, 84:1162-1172.
9. Lee D.K., Cheng R., Nguyen T., Fan T., Kariyawasam A.P., Liu Y., Osmond D.H., George S.R., O'Dowd B.F. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000, 74:34-41.
10. Kleinz M.J., Davenport A.P. Emerging roles of apelin in biology and medicine. Pharmacol Ther 2005, 107:198-211.
11. Devic E., Rizzoti K., Bodin S., Knibiehler B., Audigier Y. Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mech Dev 1999, 84:199-203.
12. Habata Y., Fujii R., Hosoya M., Fukusumi S., Kawamata Y., Hinuma S., Kitada C., Nishizawa N., Murosaki S., Kurokawa T., Onda H., Tatemoto K., Fujino M. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta 1999, 1452:25-35.
13. Tatemoto K., Takayama K., Zou M.X., Kumaki I., Zhang W., Kumano K., Fujimiya M. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001, 99:87-92.
14. Taheri S., Murphy K., Cohen M., Sujkovic E., Kennedy A., Dhillo W., Dakin C., Sajedi A., Ghatei M., Bloom S. The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun 2002, 291:1208-1212.
15. Sunter D., Hewson A.K., Dickson S.L. Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 2003, 353:1-4.
16. Masri B., Morin N., Cornu M., Knibiehler B., Audigier Y. Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. Faseb J 2004, 18:1909-1911.
17. Chen M.M., Ashley E.A., Deng D.X., Tsalenko A., Deng A., Tabibiazar R., Ben-Dor A., Fenster B., Yang E., King J.Y., Fowler M., Robbins R., Johnson F.L., Bruhn L., McDonagh T., Dargie H., Yakhini Z., Tsao P.S., Quertermous T. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 2003, 108:1432-1439.
18. Cheng X., Cheng X.S., Pang C.C. Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. Eur J Pharmacol 2003, 470:171-175.
19. Szokodi I., Tavi P., Foldes G., Voutilainen-Myllyla S., Ilves M., Tokola H., Pikkarainen S., Piuhola J., Rysa J., Toth M., Ruskoaho H. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002, 91:434-440.
20. Ashley E.A., Powers J., Chen M., Kundu R., Finsterbach T., Caffarelli A., Deng A., Eichhorn J., Mahajan R., Agrawal R., Greve J., Robbins R., Patterson A.J., Bernstein D., Quertermous T. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 2005, 65:73-82.
21. Foldes G., Horkay F., Szokodi I., Vuolteenaho O., Ilves M., Lindstedt K.A., Mayranpaa M., Sarman B., Seres L., Skoumal R., Lako-Futo Z., deChatel R., Ruskoaho H., Toth M. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 2003, 308:480-485.
22. Goetze J.P., Rehfeld J.F., Carlsen J., Videbaek R., Andersen C.B., Boesgaard S., Friis-Hansen L. Apelin: a new plasma marker of cardiopulmonary disease. Regul Pept 2006, 133:134-138.
23. Susaki E., Wang G., Cao G., Wang H.Q., Englander E.W., Greeley G.H. Apelin cells in the rat stomach. Regul Pept 2005, 129:37-41.
24. Han S., Wang G., Qiu S., de la Motte C., Wang H.Q., Gomez G., Englander E.W., Greeley G.H. Increased colonic apelin production in rodents with experimental colitis and in humans with IBD. Regul Pept 2007, 142:131-137.
25. Wang G., Anini Y., Wei W., Qi X., OC A.M., Mochizuki T., Wang H.Q., Hellmich M.R., Englander E.W., Greeley G.H. Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. Endocrinology 2004, 145:1342-1348.
26. Boucher J., Masri B., Daviaud D., Gesta S., Guigne C., Mazzucotelli A., Castan-Laurell I., Tack I., Knibiehler B., Carpene C., Audigier Y., Saulnier-Blache J.S., Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005, 146:1764-1771.
27. Sörhede Winzell M., Magnusson C., Ahren B. The APJ receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept 2005, 131:12-17.
28. Castan-Laurell I., Vitkova M., Daviaud D., Dray C., Kovacikova M., Kovacova Z., Hejnova J., Stich V., Valet P. Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ. Eur J Endocrinol 2008, 158:905-910.
29. Li L., Yang G., Li Q., Tang Y., Yang M., Yang H., Li K. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 2006, 114:544-548.
30. Erdem G., Dogru T., Tasci I., Sonmez A., Tapan S. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2008, 116:289-292.
31. Zhang Y., Shen C., Li X., Ren G., Fan X., Ren F., Zhang N., Sun J., Yang J. Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people. Diabetes Care 2009, 32:e150.
32. Dray C., Knauf C., Daviaud D., Waget A., Boucher J., Buleon M., Cani P.D., Attane C., Guigne C., Carpene C., Burcelin R., Castan-Laurell I., Valet P. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 2008, 8:437-445.
33. Mulder H., Lindh A.C., Sundler F. Islet amyloid polypeptide gene expression in the endocrine pancreas of the rat: a combined in situ hybridization and immunocytochemical study. Cell Tissue Res 1993, 274:467-474.
34. Myrsen U., Ahren B., Sundler F. Dexamethasone-induced neuropeptide Y expression in rat islet endocrine cells. Rapid reversibility and partial prevention by insulin. Diabetes 1996, 45:1306-1316.
35. Bottcher G., Sjoberg J., Ekman R., Hakanson R., Sundler F. Peptide YY in the mammalian pancreas: immunocytochemical localization and immunochemical characterization. Regul Pept 1993, 43:115-130.
36. Wierup N., Svensson H., Mulder H., Sundler F. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept 2002, 107:63-69.
37. Wierup N., Bjorkqvist M., Kuhar M.J., Mulder H., Sundler F. CART regulates islet hormone secretion and is expressed in the beta-cells of type 2 diabetic rats. Diabetes 2006, 55:305-311.
38. Lyssenko V., Nagorny C.L., Erdos M.R., Wierup N., Jonsson A., Spegel P., et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009, 41:82-88.
39. Wierup N., Richards W.G., Bannon A.W., Kuhar M.J., Ahren B., Sundler F. CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight. Regul Pept 2005, 129:203-211.
40. Wierup N., Bjorkqvist M., Westrom B., Pierzynowski S., Sundler F., Sjolund K. Ghrelin and motilin are cosecreted from a prominent endocrine cell population in the small intestine. J Clin Endocrinol Metab 2007, 92:3573-3581.
41. Fex M., Wierup N., Nitert M.D., Ristow M., Mulder H. Rat insulin promoter 2-Cre recombinase mice bred onto a pure C57BL/6J background exhibit unaltered glucose tolerance. J Endocrinol 2007, 194:551-555.
42. Goto M.E.T., Felldin M., Foss A., Kallen R., Salmela K., Tibell A., Tufveson G., Fujimori K., Engkvist M., Korsgren O. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 2004, 78:1367-1375.
43. Hohmeier H.E., Mulder H., Chen G., Henkel-Rieger R., Prentki M., Newgard C.B. Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 2000, 49:424-430.
44. Wei L., Hou X., Tatemoto K. Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regul Pept 2005, 132:27-32.